US Broker Ratings

STERIS plc (STE) Stock Analysis: Unpacking the 10.26% Potential Upside

Investors with a keen eye on the healthcare sector should take note of STERIS plc (NYSE: STE), a pivotal player in the medical devices industry. Headquartered in Mentor, Ohio, STERIS..

HealthEquity, Inc. (HQY) Investor Outlook: Exploring a 29.84% Upside Potential in the Healthcare Sector

HealthEquity, Inc. (HQY), a prominent player in the Health Information Services industry, offers an intriguing investment opportunity within the healthcare sector. Based in Draper, Utah, the company provides a robust..

Jazz Pharmaceuticals (JAZZ) Investor Outlook: Why Analysts See a 24.94% Upside Potential

Jazz Pharmaceuticals plc (JAZZ) stands as a dynamic player in the biotechnology sector, commanding significant attention from investors due to its promising product portfolio and robust growth potential. Headquartered in..

Qiagen N.V. (QGEN) Investor Outlook: Exploring a Potential 11.46% Upside with Strong Buy Ratings

For investors keen on the healthcare sector, particularly in diagnostics and research, Qiagen N.V. (NYSE: QGEN) presents a compelling case with its robust growth potential and market positioning. With a..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with a 16.53% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) is a healthcare company that stands at the forefront of medical innovation, particularly in the field of organ transplant therapy. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth Amidst a 7.86% Potential Upside

For investors with an eye on the healthcare sector, Bruker Corporation (BRKR) presents a compelling opportunity. With its current market cap standing at $7.29 billion, Bruker operates in the medical..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 2.77% Potential Upside with a Strong Buy Rating

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a global powerhouse in the healthcare sector, has consistently demonstrated resilience in the competitive landscape of drug manufacturing. Despite its rich history and diverse..

Nuvalent, Inc. (NUVL) Stock Analysis: A 36% Upside Potential in the Biotech Arena

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the spotlight in the biotechnology sector with a robust market capitalization of $8.08 billion. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is pioneering..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a Potential 3.27% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the global healthcare sector, specializing in both specialty and generic drug manufacturing. Based in Hyderabad, India, the company’s..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings and a Potential 23.56% Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector with its innovative diagnostic and therapeutic products. Based in Bedford, Massachusetts, Lantheus Holdings has been a key player..

Zoetis Inc. (ZTS) Stock Analysis: Uncovering a 25% Potential Upside in the Animal Health Leader

Zoetis Inc. (NYSE: ZTS) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. With a market capitalization of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Uncovering a 14.52% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing case for investors seeking opportunities in the life sciences and clinical..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Its Market Position Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector specializing in diagnostics and research, commands a significant presence in the genetic and genomic analysis market. Headquartered in San..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 30.98% Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player in the medical instruments and supplies industry, is capturing the attention of investors with its solid market position and promising growth prospects. With..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Sector with Solid Revenue Growth and Analyst Confidence

Exelixis, Inc. (NASDAQ: EXEL) stands as a significant player in the biotechnology industry, primarily focusing on developing treatments for challenging cancer types. With a market capitalization of $12.45 billion, Exelixis..

RadNet, Inc. (RDNT) Stock Analysis: A 25% Upside Potential Amidst Robust Revenue Growth

RadNet, Inc. (NASDAQ: RDNT) is capturing investor attention with its impressive 25.38% potential upside, as indicated by analyst target prices. This healthcare sector stalwart, specializing in diagnostics and research, offers..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 10% Upside Amid Robust Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW) is making waves in the healthcare sector, particularly within the medical devices industry. With a significant market cap of $50.99 billion, the company stands as..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating the 6.27% Upside in Biotech Innovation

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a prominent player in the biotechnology sector, primarily focusing on therapies for cystic fibrosis and other severe diseases. As of the latest data,..

Charles River Laboratories (CRL): Investor Outlook Reveals Mixed Momentum Amidst Steady Analyst Confidence

Charles River Laboratories International, Inc. (NYSE: CRL) stands at a fascinating juncture for investors, blending a strong market presence with challenging financial metrics. Headquartered in Wilmington, Massachusetts, the company has..

Hologic, Inc. (HOLX) Stock Analysis: A Healthcare Powerhouse with Solid Growth Prospects

Hologic, Inc. (NASDAQ: HOLX) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $16.62 billion, this Massachusetts-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds